Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Otonomy completes enrollment in trial of AuriPro for otitis media with tympanostomy tubes

May 11, 2015

Interim analysis completed for phase III trial of AM-101 in post-acute tinnitus

March 11, 2015

Otonomy submits NDA to the FDA for AuriPro

March 2, 2015

Next Science wound gel inhibits biofilm development in ear infection models

Feb. 4, 2015

Auris Medical updates on phase III trial of AM-101 in tinnitus

Jan. 16, 2015

FDA approves ear drop formulation of finafloxacin for acute otitis externa

Dec. 18, 2014

Salvat reports topline phase III results for combination otic solution in AOMT

Oct. 3, 2014

Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects

Sep. 19, 2014

NicOx obtains antiviral eye drop program from Marinomed

Sep. 17, 2014

Otonomy releases phase III data for AuriPro in middle ear effusion

July 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...